Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2003

01-02-2003 | Case Report

Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation

Authors: Heiwa Kanamori, Yumiko Takaishi, Maki Takabayashi, Masatsugu Tanaka, Satoshi Yamaji, Naoto Tomita, Katsumichi Fujimaki, Shin Fujisawa, Shinichiro Watanabe, Michio Matsuzaki, Yoshiaki Tshigatsubo

Published in: International Journal of Hematology | Issue 2/2003

Login to get access
Metadata
Title
Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation
Authors
Heiwa Kanamori
Yumiko Takaishi
Maki Takabayashi
Masatsugu Tanaka
Satoshi Yamaji
Naoto Tomita
Katsumichi Fujimaki
Shin Fujisawa
Shinichiro Watanabe
Michio Matsuzaki
Yoshiaki Tshigatsubo
Publication date
01-02-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02983218

Other articles of this Issue 2/2003

International Journal of Hematology 2/2003 Go to the issue

OriginalPaper

Clinical Manifestations of Paroxysmal Nocturnal Hemoglobinuria: Present State and Future Problems

Case Report

Pyomyositis as a Focus of Infection in Hematological Disorders: A Report of 3 Cases

OriginalPaper

Prevalence of Intravascolar Large B-Cell Lymphoma with Bone Marrow Involvement at Initial Presentation

OriginalPaper

Molecular Genetics of Paroxysmal Nocturnal Hemoglobinuria

Letter to the Editor

Pharmacokinetics of a Standard Dose of Cytarabine in a Patient with Acute Promyelocytic Leukemia Undergoing Continuous Ambulatory Peritoneal Dialysis

OriginalPaper

Granulocyte Colony-Stimulating Factor-induced Terminal Maturation of Human Myeloid Cells Is Specifically Associated with Up-Regulation of Receptor-Mediated Function and CD10 Expression
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits